Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Rates and Predictors of Vaccinations Among Inflammatory Bowel Disease Patients Receiving Anti-Tumor Necrosis Factor Agents.

Pham HV, Hasan I, Udaltsova N, Pham K, Abramson O, Armstrong MA, Postlethwaite D, Li D.

Dig Dis Sci. 2018 Jan;63(1):209-217. doi: 10.1007/s10620-017-4716-6. Epub 2017 Aug 23.

PMID:
28836068
2.

Infections Requiring Hospitalization as Predictors of Pediatric-Onset Crohn's Disease and Ulcerative Colitis.

Hutfless S, Abramson O, Heyman MB, Bayless TM, Li DK, Winthrop K, Herrinton LJ.

Gastroenterol Res Pract. 2015;2015:690581. doi: 10.1155/2015/690581. Epub 2015 May 14.

3.

Racial and ethnic differences in health care utilization and outcomes among ulcerative colitis patients in an integrated health-care organization.

Li D, Collins B, Velayos FS, Liu L, Lewis JD, Allison JE, Flowers NT, Hutfless S, Abramson O, Herrinton LJ.

Dig Dis Sci. 2014 Feb;59(2):287-94. doi: 10.1007/s10620-013-2908-2. Epub 2013 Oct 31.

PMID:
24173809
4.

Plasmablast frequency and trafficking receptor expression are altered in pediatric ulcerative colitis.

Tarlton NJ, Green CM, Lazarus NH, Rott L, Wong AP, Abramson ON, Bremer M, Butcher EC, Abramson T.

Inflamm Bowel Dis. 2012 Dec;18(12):2381-91. doi: 10.1002/ibd.22962. Epub 2012 Apr 5.

5.

Prenatal and perinatal characteristics associated with pediatric-onset inflammatory bowel disease.

Hutfless S, Li DK, Heyman MB, Bayless TM, Abramson O, Herrinton LJ.

Dig Dis Sci. 2012 Aug;57(8):2149-56. doi: 10.1007/s10620-012-2128-1. Epub 2012 Mar 24.

6.

The incidence of hepatosplenic T-cell lymphoma in a large managed care organization, with reference to anti-tumor necrosis factor therapy, Northern California, 2000-2006.

Herrinton LJ, Liu L, Abramson O, Jaffe ES.

Pharmacoepidemiol Drug Saf. 2012 Jan;21(1):49-52. doi: 10.1002/pds.2216. Epub 2011 Aug 8.

7.

Prevalence of colorectal cancer surveillance for ulcerative colitis in an integrated health care delivery system.

Velayos FS, Liu L, Lewis JD, Allison JE, Flowers N, Hutfless S, Abramson O, Perry GS, Herrinton LJ.

Gastroenterology. 2010 Nov;139(5):1511-8. doi: 10.1053/j.gastro.2010.07.039. Epub 2010 Jul 24.

PMID:
20659470
8.

Incidence, prevalence, and time trends of pediatric inflammatory bowel disease in Northern California, 1996 to 2006.

Abramson O, Durant M, Mow W, Finley A, Kodali P, Wong A, Tavares V, McCroskey E, Liu L, Lewis JD, Allison JE, Flowers N, Hutfless S, Velayos FS, Perry GS, Cannon R, Herrinton LJ.

J Pediatr. 2010 Aug;157(2):233-239.e1. doi: 10.1016/j.jpeds.2010.02.024. Epub 2010 Apr 18.

PMID:
20400099
9.

Incidence of stricturing and penetrating complications of Crohn's disease diagnosed in pediatric patients.

Gupta N, Bostrom AG, Kirschner BS, Ferry GD, Gold BD, Cohen SA, Winter HS, Baldassano RN, Abramson O, Smith T, Heyman MB.

Inflamm Bowel Dis. 2010 Apr;16(4):638-44. doi: 10.1002/ibd.21099.

10.

Timing of myelosuppression during thiopurine therapy for inflammatory bowel disease: implications for monitoring recommendations.

Lewis JD, Abramson O, Pascua M, Liu L, Asakura LM, Velayos FS, Hutfless SM, Alison JE, Herrinton LJ.

Clin Gastroenterol Hepatol. 2009 Nov;7(11):1195-201; quiz 1141-2. doi: 10.1016/j.cgh.2009.07.019. Epub 2009 Jul 22.

11.

Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.

Herrinton LJ, Liu L, Fireman B, Lewis JD, Allison JE, Flowers N, Hutfless S, Velayos FS, Abramson O, Altschuler A, Perry GS.

Gastroenterology. 2009 Aug;137(2):502-11. doi: 10.1053/j.gastro.2009.04.063. Epub 2009 May 13.

PMID:
19445944
12.

Presentation and disease course in early- compared to later-onset pediatric Crohn's disease.

Gupta N, Bostrom AG, Kirschner BS, Cohen SA, Abramson O, Ferry GD, Gold BD, Winter HS, Baldassano RN, Smith T, Heyman MB.

Am J Gastroenterol. 2008 Aug;103(8):2092-8. doi: 10.1111/j.1572-0241.2008.02000.x.

13.

Development of extraintestinal manifestations in pediatric patients with inflammatory bowel disease.

Jose FA, Garnett EA, Vittinghoff E, Ferry GD, Winter HS, Baldassano RN, Kirschner BS, Cohen SA, Gold BD, Abramson O, Heyman MB.

Inflamm Bowel Dis. 2009 Jan;15(1):63-8. doi: 10.1002/ibd.20604.

14.

Patterns of infliximab use among Crohn's disease patients in a community setting.

Pressman AR, Hutfless S, Velayos F, Fireman B, Lewis JD, Allison J, Abramson O, Herrinton LJ.

Inflamm Bowel Dis. 2008 Sep;14(9):1265-72. doi: 10.1002/ibd.20483.

PMID:
18452199
15.

Gender differences in presentation and course of disease in pediatric patients with Crohn disease.

Gupta N, Bostrom AG, Kirschner BS, Ferry GD, Winter HS, Baldassano RN, Gold BD, Abramson O, Smith T, Cohen SA, Heyman MB.

Pediatrics. 2007 Dec;120(6):e1418-25.

PMID:
18055660
16.

Risk factors for initial surgery in pediatric patients with Crohn's disease.

Gupta N, Cohen SA, Bostrom AG, Kirschner BS, Baldassano RN, Winter HS, Ferry GD, Smith T, Abramson O, Gold BD, Heyman MB.

Gastroenterology. 2006 Apr;130(4):1069-77.

PMID:
16618401
17.

Watermarks encrypted in a concealogram and deciphered by a modified joint-transform correlator.

Abookasis D, Montal O, Abramson O, Rosen J.

Appl Opt. 2005 May 20;44(15):3019-23.

PMID:
15929293
18.

Use of spotted oligonucleotide arrays for large-scale analysis of mammalian gene expression.

Erle DJ, Koth L, Abramson O, Rodriguez MW, Barczak A.

Chest. 2002 Mar;121(3 Suppl):80S. No abstract available.

PMID:
11893700
19.
20.

Current status of pediatric liver transplantation.

Abramson O, Rosenthal P.

Clin Liver Dis. 2000 Aug;4(3):533-52. Review.

PMID:
11232160
21.

Successful non-surgical treatment of Candida tropicalis endocarditis with liposomal amphotericin-B (AmBisome).

Melamed R, Leibovitz E, Abramson O, Levitas A, Zucker N, Gorodisher R.

Scand J Infect Dis. 2000;32(1):86-9.

PMID:
10716084
22.

Bacteriologic response to oral cephalosporins: are established susceptibility breakpoints appropriate in the case of acute otitis media?

Dagan R, Abramson O, Leibovitz E, Greenberg D, Lang R, Goshen S, Yagupsky P, Leiberman A, Fliss DM.

J Infect Dis. 1997 Nov;176(5):1253-9.

PMID:
9359726
23.

Rapid detection of Brucella melitensis from blood cultures by a commercial system.

Yagupsky P, Peled N, Press J, Abu-Rashid M, Abramson O.

Eur J Clin Microbiol Infect Dis. 1997 Aug;16(8):605-7.

PMID:
9323475
24.

Failure of short antimicrobial treatments for human brucellosis.

Abramson O, Abu-Rashid M, Gorodischer R, Yagupsky P.

Antimicrob Agents Chemother. 1997 Jul;41(7):1621-2. No abstract available.

25.

Antibiotic treatment in acute otitis media: 'in vivo' demonstration of antibacterial activity.

Dagan R, Fliss DM, Leibovitz E, Abramson O, Greenberg D, Lang R, Goshen S, Yagupsky P, Leiberman A.

Clin Microbiol Infect. 1997 Jun;3 Suppl 3:S43-S48.

26.

Comparison of BACTEC 9240 Peds Plus medium and isolator 1.5 microbial tube for detection of Brucella melitensis from blood cultures.

Yagupsky P, Peled N, Press J, Abramson O, Abu-Rashid M.

J Clin Microbiol. 1997 Jun;35(6):1382-4.

27.

Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine.

Dagan R, Melamed R, Muallem M, Piglansky L, Greenberg D, Abramson O, Mendelman PM, Bohidar N, Yagupsky P.

J Infect Dis. 1996 Dec;174(6):1271-8.

PMID:
8940218
28.

Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin.

Dagan R, Abramson O, Leibovitz E, Lang R, Goshen S, Greenberg D, Yagupsky P, Leiberman A, Fliss DM.

Pediatr Infect Dis J. 1996 Nov;15(11):980-5.

PMID:
8933545
29.

Severe complications of measles requiring intensive care in infants and young children.

Abramson O, Dagan R, Tal A, Sofer S.

Arch Pediatr Adolesc Med. 1995 Nov;149(11):1237-40.

PMID:
7581755
30.

Commercial dialysate inhibits TNF alpha mRNA expression and NF-kappa B DNA-binding activity in LPS-stimulated macrophages.

Douvdevani A, Abramson O, Tamir A, Konforty A, Isakov N, Chaimovitz C.

Kidney Int. 1995 Jun;47(6):1537-45.

31.

Fetal pseudohypoaldosteronism: another cause of hydramnios.

Greenberg D, Abramson O, Phillip M.

Acta Paediatr. 1995 May;84(5):582-4.

PMID:
7633160
32.

Nephrocalcinosis in pseudohypoaldosteronism and the effect of indomethacin therapy.

Shalev H, Ohali M, Abramson O.

J Pediatr. 1994 Aug;125(2):246-8.

PMID:
8040773
33.

Hematologic manifestations of brucellosis in children.

Shalev H, Abramson O, Levy J.

Pediatr Infect Dis J. 1994 Jun;13(6):543-5. No abstract available.

PMID:
8078747
34.

Pseudohypoaldosteronism in a preterm infant: intrauterine presentation as hydramnios.

Abramson O, Zmora E, Mazor M, Shinwell ES.

J Pediatr. 1992 Jan;120(1):129-32.

PMID:
1731010
35.

Detection and treatment of brucellosis by screening a population at risk.

Abramson O, Rosenvasser Z, Block C, Dagan R.

Pediatr Infect Dis J. 1991 Jun;10(6):434-8.

PMID:
1852539

Supplemental Content

Loading ...
Support Center